Reports second quarter 2026 financial results
Investors learn if the company made more or less money than expected.
Gilead Sciences, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Investors learn if the company made more or less money than expected.
The company borrowed money by selling bonds, which affects future obligations.
Shows details about how the company is raising borrowed money.
Shows details about how the company is raising borrowed money.
Official records show the company's financial position three months into the year.
Investors learn if the company made more or less money than expected.
Owners voted on who leads the company and who checks its finances.
Stocky reads Gilead Sciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Gilead Sciences, Inc.'s most recent tracked filing was a 8-K on 4 Aug 2026: Reports second quarter 2026 financial results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.